Skip to main content
Premium Trial:

Request an Annual Quote

Ocimum Partners with Jivan Biologics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ocimum Biosolutions said today that it will partner with Jivan Biologics to offer several transcriptome profiling services.

Hyderabad, India-based Ocimum said that it will provide sequencing-based transcriptome profiling services utilizing Jivan's bioinformatics infrastructure to offer services for exon mutation studies, splice studies, and digital gene expression efforts.

High-throughput analysis of transcriptome profiles is used in clinical research, such as cancer studies that aim to understand gene expression patterns that predict tumor progression.

"Combining Ocimum's expertise in the genomics arena with Jivan's strengths in RNA sequencing and expression will empower the research community in getting better insights into gene expression studies," Ocimum CEO and Founder Anu Acharya said in a statement.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.